Thyrotropin-releasing hormone (TRH, pGlu-His-Pro-NH(2)) and the structurally related [Glu(2)]TRH (pGlu-Glu-Pro-NH(2)) are endogenous peptides with a plethora of actions in the central nervous system. Many centrally-mediated effects of TRH are shared with those of [Glu(2)]TRH, although the involvement of different receptors is presumed. The analeptic action is the best-known TRH-related central nervous system effect. While [Glu(2)]TRH itself is analeptic, its co-administration with TRH into mice produced a dose-dependent attenuation of TRH-evoked reversal of barbiturate-induced sleeping time. This finding is in agreement with our previous observations that [Glu(2)]TRH significantly attenuates TRH-induced hippocampal extracellular acetylcholine release. Taken together, [Glu(2)]TRH may be considered as a negative modulator for the cholinergic effect of TRH in the mouse brain. Copyright 2010 Elsevier Inc. All rights reserved.
Thyrotropin-releasing hormone (n class="Gene">TRH, pGlu-His-Pro-NH(2)) and the structurally related [Glu(2)]TRH (pGlu-Glu-Pro-NH(2)) are endogenous peptides with a plethora of actions in the central nervous system. Many centrally-mediated effects of TRH are shared with those of [Glu(2)]TRH, although the involvement of different receptors is presumed. The analeptic action is the best-known TRH-related central nervous system effect. While [Glu(2)]TRH itself is analeptic, its co-administration with TRH into miceproduced a dose-dependent attenuation of TRH-evoked reversal of barbiturate-induced sleeping time. This finding is in agreement with our previous observations that [Glu(2)]TRH significantly attenuates TRH-induced hippocampal extracellular acetylcholine release. Taken together, [Glu(2)]TRH may be considered as a negative modulator for the cholinergic effect of TRH in the mouse brain. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Laszlo Prokai; Katalin Prokai-Tatrai; Alevtina D Zharikova; Vien Nguyen; Pal Perjesi; Stanley M Stevens Journal: J Med Chem Date: 2004-11-18 Impact factor: 7.446
Authors: Gaia A Scalabrino; Nicola Hogan; Kathy M O'Boyle; Gillian R Slator; Daniel J Gregg; Christopher M Fitchett; Sylvia M Draper; Geoffrey W Bennett; Patricia M Hinkle; Karl Bauer; Carvell H Williams; Keith F Tipton; Julie A Kelly Journal: Neuropharmacology Date: 2007-02-28 Impact factor: 5.250
Authors: Marieke Hyke Algera; Joseph F Cotten; Monique van Velzen; Marieke Niesters; Martijn Boon; Daniel S Shoham; Kaye E Dandrea; Rutger van der Schrier; Albert Dahan Journal: Pharmacol Res Perspect Date: 2022-06